Labeling Rule Requires Sponsors To Start Safety Discussions With FDA Earlier
Executive Summary
Sponsors will need to discuss safety updates to product labeling in the new format ahead of a submission to the agency in order to facilitate the prior approval necessary under the physician labeling rule